Beaumont Financial Partners, LLC Abbott Laboratories Transaction History

Beaumont Financial Partners, LLC

$1.04 Billion
Q3 2022

A detailed history of Beaumont Financial Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 108,295 shares of ABT stock, worth $14 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

108,295

Previous 108,270 0.02%

Holding current value

$14 Million

Previous $11.8 Million 10.92%

% of portfolio

1.01%

Previous 1.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $2,419 - $2,800	25 Added 0.02%	108,295 $10.5 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $61,752 - $74,638	-605 Reduced 0.56%	108,270 $11.8 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $41,845 - $51,027	-367 Reduced 0.34%	108,875 $12.9 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $242,266 - $296,641	-2,097 Reduced 1.88%	109,242 $15.4 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $208,238 - $230,372	-1,785 Reduced 1.58%	111,339 $13.2 Million
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $239,825 - $282,309	2,267 Added 2.04%	113,124 $13.1 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $34,828 - $41,033	-320 Reduced 0.29%	110,857 $13.3 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $878,535 - $957,352	-8,367 Reduced 7.0%	111,177 $12.2 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $133,427 - $162,038	-1,456 Reduced 1.2%	119,544 $13 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $190,889 - $244,314	2,493 Added 2.1%	121,000 $11.1 Million
Q1 2020 May 08, 2020	SELL	$62.82 - $91.86 $176,587 - $258,218	-2,811 Reduced 2.32%	118,507 $9.35 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $100,963 - $112,396	1,286 Added 1.07%	121,318 $10.5 Million
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $5,401 - $5,856	66 Added 0.06%	120,032 $10 Million
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $161,356 - $188,190	2,214 Added 1.88%	119,966 $10.1 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $76,417 - $92,389	-1,154 Reduced 0.97%	117,752 $9.41 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $60,708 - $68,774	-926 Reduced 0.77%	118,906 $8.6 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $19,337 - $23,328	-318 Reduced 0.26%	119,832 $8.79 Million
Q2 2018 Aug 06, 2018	BUY	$57.57 - $63.54 $68,968 - $76,120	1,198 Added 1.01%	120,150 $7.33 Million
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $56,945 - $64,383	1,012 Added 0.86%	118,952 $7.13 Million
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $44,232 - $47,355	-824 Reduced 0.69%	117,940 $6.73 Million
Q3 2017 Oct 31, 2017	SELL	$48.06 - $53.64 $594,694 - $663,741	-12,374 Reduced 9.44%	118,764 $6.34 Million
Q2 2017 Aug 11, 2017	BUY	N/A	131,138	131,138 $6.38 Million

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.

Account

Beaumont Financial Partners, LLC Abbott Laboratories Transaction History